NCT03345498View on ClinicalTrials.gov

Entecavir for Decompensated HBV Cirrhosis

CompletedOBSERVATIONAL
Enrollment

32

Participants

Timeline

Start Date

January 1, 2017

Primary Completion Date

June 30, 2018

Study Completion Date

December 31, 2018

Conditions
Hepatitis BLiver Cirrhosis
Interventions
DRUG

Entecavir

Entecavir is the antiviral drug of choice recommended for hepatitis B virus treatment in presence of decompensated cirrhosis

Trial Locations (1)

226014

Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow

All Listed Sponsors
lead

Sanjay Gandhi Postgraduate Institute of Medical Sciences

OTHER_GOV

NCT03345498 - Entecavir for Decompensated HBV Cirrhosis | Biotech Hunter | Biotech Hunter